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Abstract 
Background and objectives: Sedation-analgesia is recommended for comfortable colonoscopy 
procedures, which are invasive and can be painful. This study aimed to compare the combinations 
of propofol-alfentanil and propofol-fentanyl for sedation-analgesia in elective colonoscopy 
patients.
Methods: This prospective and randomized study was planned in ASA I-II groups and included 80 
patients between the ages of 18 and 65 years. Sedation-analgesia induction was performed as 
1 μg.kg-1 fentanyl, 1 mg.kg-1 propofol in the propofol-fentanyl group (Group PF) and 10 μg.kg-1 
alfentanil, 1 mg.kg-1 propofol in the propofol-alfentanil group (Group PA). Patients’ scores were 
limited to 3-4 values on the Ramsey Sedation Scale (RSS) by 0.5 mg.kg-1 bolus additional doses of 
propofol in sedation-analgesia maintenance. We recorded demographical data, heart rate, mean 
arterial pressure (MAP), oxygen saturation of hemoglobin (SpO2), RSS value, colonoscopy time, 
total dose of propofol, complications, recovery time, and discharge time, as well as colonoscopist 
and patient satisfaction scores.
Results: MAP at the 15th minute in Group PA was signiﬁ cantly higher than in Group PF (p = 0.037). 
Group PA’s beginning mean heart rate was higher than the mean heart rate at subsequent readings 
(p = 0.012, p = 0.002). The mean total propofol dose of Group PA was signiﬁ cantly higher than 
the total dose of Group PF (p = 0.028). The mean recovery time of Group PA was signiﬁ cantly 
longer than that of Group PF (p = 0.032).
Conclusion: Fentanyl provides better operative conditions and reduces the need for additional 
propofol doses. These advantages cause a shorter recovery time. Therefore, propofol-fentanyl 
is superior to the propofol-alfentanil for sedation-analgesia in colonoscopy.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
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Introduction
Due to the frequency of colorectal malignancies in industrial 
countries, diagnostic and therapeutic colonoscopy rates 
have increased dramatically. Colonoscopy-induced pain and 
anxiety affects both patient and colonoscopist comfort 1. The 
best sedation/analgesia type for gastrointestinal endoscopic 
procedures is still not clear 2. Although some studies recom-
mend that the colonoscopy procedure can be performed 
without sedation, various other studies have reported this 
is not possible and that sedation administration before the 
procedure is safer for both patient and colonoscopist 3-5. Both 
anesthesia and sedation-analgesia are options for colonos-
copy procedures 6, but conscious sedation is recommended 1. 
Conscious sedation allows the patient to give responses to 
verbal or tactile stimulation and provides the attendance of 
respiratory and cardiovascular functions 1. 
Doctors performing colonoscopy screenings through-
out the world tend to prefer sedation-analgesia. Mida zo-
lam, propofol and/or alfentanil or pethidine combinations, 
α-agonists, and neuroleptics are used for sedation-anal-
gesia 6,7.
This study aimed to compare the hemodynamic ef-
fects, recovery and discharge times, patient-colonoscopist 
satisfaction, and complications of propofol-fentanyl and 
propofol-alfentanil combinations in elective colonoscopy 
procedures.
Material and Methods
After obtaining the Ethics Committee’s approval and the 
patients’ written informed consents, this prospective and 
randomized 80-patient study proceeded in Şişli Etfal Training 
and Research Hospital, Istanbul, Turkey. The research team 
selected a group of ASA I-II patients between 18 and 65 years 
scheduled for elective colonoscopy screening. Researchers 
veriﬁ ed the status of patients’ 8-hour fasting period and 
the absence of alcohol or sedative drug use 24 hours before 
the colonoscopy procedure. The same anesthesiologist ad-
ministered sedation-analgesia on all patients. The exclusion 
criterions of this study were pregnancy, gastrointestinal 
hemorrhage, known or predicted airway difﬁ culty, alcohol 
or drug addiction, neuropsychiatric disease, severe heart or 
respiratory insufﬁ ciency, and sedative drug allergy.
An independent nurse performed randomization by 
sequentially opening numbered opaque envelopes with 
group allocation cards in a random computer generated 
sequence. Patients were not informed of the group in which 
they were included.
We explained the oral scoring system to the patients, 
which is on a scale of 1 to 10 and necessary to evaluate the 
patient satisfaction. After patients were admitted to the 
gastrointestinal endoscopy unit, intravenous (IV) catheteriza-
tion was performed with 18-gauge IV catheters and a 0.9% 
NaCl infusion was started; patients received no premedica-
tion. The lateral positioned patients were monitored with 
noninvasive systemic mean arterial pressure (MAP), 3-channel 
ECGs, and pulse oximetry (SpO2). Patients received 3L.min
-1 
oxygen by nasal catheter. 
The research team performed sedation-analgesia induc-
tion as 1 μg.kg-1 fentanyl and 1 mg.kg-1 propofol in Group 
PF and 10 μg.kg-1 alfentanil and 1 mg.kg-1 propofol in Group 
PA. After the beginning of the colonoscopy screening, the 
patients’ scores were limited to 3-4 values on the Ramsey 
Sedation Scale (RSS) (Table 1) by 0.5 mg.kg-1 bolus additional 
doses of propofol in sedation-analgesia maintenance. We 
recorded heart rate, MAP, SpO2, and RSS values before the 
procedure, at the beginning of the colonoscopy screening, 
and at 5-minute intervals during the procedure.
We established colonoscopy time as the time from induc-
tion to the end of the colonoscopy screening. The recovery 
time was the time from induction until the RSS scores pro-
gressed to value 2. We recorded total propofol doses and 
complications. After the procedure, patients with scores 
of 9 or greater, according to the Aldrete Score (Table 2), 
were discharged. After recovery, patients orally scored 
satisfaction on a scale of 1 to 10 (1: not satisﬁ ed, 10: very 
satisﬁ ed). Colonoscopist satisfaction was scored with 10 cm 
visual analog scale. We recorded colonoscopist and patient 
satisfaction scores. 
We recorded anesthesia and endoscopy-related complica-
tions that appeared during or after procedure, such as allergic 
reactions, bradycardia, tachycardia, hypotension, hyper-
tension, respiratory depression, desaturation, perforation, 
bleeding, nausea and vomiting. Desaturation was deﬁ ned as 
the decrease of oxygen saturation to below 85%.
Table 1 - Ramsay Sedation Scale.
Deﬁ nition Score
Patient is anxious and agitated or restless, or both 1
Patient is cooperative, oriented and calm 2
Patient responds to commands only 3
Patient exhibits brisk response to light glabellar tap or loud auditory stimulus 4
Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus 5
Patient exhibits no response 6
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We calculated the sample sizes with the assumption of at 
least 30% possible difference in our study between any two 
groups. Therefore, we allocated 40 patients into each group 
to obtain an alpha error of 5% and statistical power of 80%.
For data evaluation and descriptive statistics (mean, stan-
dard deviation), researchers used paired variance analysis 
for repeated measures of the groups and the Newman-Keuls 
multiple comparison test for subgroups. We used an inde-
pendent t-test for comparisons between the two groups and 
the chi-square test for comparison of qualitative parameters. 
Results were considered statistically signiﬁ cant when the p 
value was under 0.05.
Results
Age, sex, weight, ASA values, colonoscopy times, and 
complication rates were similar in both groups (Table 3). 
Complications were apparent in 21 patients. Although there 
was no respiratory depression, 8 patients from Group PF, and 
12 from Group PA experienced desaturation. These patients 
did not need endotracheal intubation or mask ventilation; 
vocal or tactile stimuli produced adequate recovery from 
desaturation. Only one patient had nausea and vomiting; 
this patient was in Group PA. All of the patients that experi-
enced complications were discharged safely. We did not see 
endoscopy-related complications.
The MAP mean at the 15th minute in Group PA was signiﬁ -
cantly higher than in Group PF (p = 0.037), but there were 
no differences between the two groups at all other times 
of MAP (Table 4). Similar to Group PA, Group PF showed no 
signiﬁ cant differences when the beginning MAP mean was 
compared with the mean at all other times. 
There was no difference in mean heart rate between 
the two groups at any time. Although mean heart rates 
were similar in Group PF for all recording times, signiﬁ cant 
differences were found in Group PA (p = 0.0001). Group PA’s 
beginning mean heart rate was signiﬁ cantly higher than the 
mean heart rates for all other recording times (p = 0.002, 
p = 0.012), which were similar to each other (Table 5). There 
were no signiﬁ cant differences between the two groups in 
mean oxygen saturation values (Figure 1).
Table 2 - Aldrete Score.
Deﬁ nition Score
Activity
Able to move 4 extremities voluntarily or on command
Able to move 2 extremities voluntarily or on command
Able to move 0 extremities voluntarily or on command
2
1
0
Respiration
Able to deep breath and cough freely 
Dyspnea or limited breathing 
Apnea 
2
1
0
Circulation
Blood Pressure < ± 20% of Preanesthetic level 
Blood Pressure < ± 20-50% of Preanesthetic level  
Blood Pressure < ± 50% of Preanesthetic level
2
1
0
Consciousness
Fully Awake 
Arousable on calling 
Not responding
2
1
0
O2 Saturation
Maintains > 92% on room air 
Needs O2 inhalation to maintain O2 saturation > 90% 
Saturation < 90% even with supplemental oxygen 
2
1
0
Beggining 1st min. 5th min. 10th min.  15th min. 20th min. 25th min. 30th min.
                Mean Oxygen Saturation Values
100
99
98
97
96
95
94
Group PF Group PA
Figure 1 - Mean Oxygen Saturation Values of the Groups.
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Table 3 - Distributions of Age, ASA, Sex, Weight, Complications and Colonoscopy Times in Groups.
Group PF Group PA p
Age (year) 51.8 ± 12.65 54.5 ± 15.16 0.390
Sex
Female 22 (55%) 23 (57.5%)
0.822
Male
18 (45%) 17 (42.5%)
Weight (kg) 77.97 ± 14.02 80.03 ± 11.22 0.472
ASA
I 14 (35%) 11 (27.5%)
0.573II 26 (65%) 29 (72.5%) 
Colonoscopy Time (minute) 17.5 ± 7.39 20.68 ± 10.2 0.115
Complication
Absent 32 (80%) 27 (67.5%)
0.204Present 8 (20%) 13 (32.5%)
Table 4 - Mean MAP Values of the Groups.
MAP Group PF Group PA p
Beginning 93.32 ± 18.25 96.7 ± 18.81 0.423
1st Minute 84.2 ± 100.61 72.95 ± 13.24 0.491
5th Minute 75.33 ± 16.29 76.8 ± 15.29 0.681
10th Minute 80.37 ± 14.32 82.81 ± 20.41 0.550
15th Minute 75.95 ± 10.87 85.1 ± 17.76 0.037*
20th Minute 83.08 ± 13.41 87.09 ± 21.78 0.553
25th Minute 89.4 ± 17.19 86.45 ± 29.69 0.787
30th Minute 81.67 ± 2.52 84.5 ± 25.03 0.854
Table 5 - Mean Heart Rates of the Groups.
Heart Rate Group PF Group PA p
Beginning 84.98 ± 13.19 89.10 ± 11.64 0.142
1st Minute 81.8 ± 10.87 82.48 ± 13.06 0.802
5th  Minute 77.44 ± 9.71 76.88 ± 12.43 0.824
10th Minute 76.59 ± 10.34 77.41 ± 11.51 0.479
15th Minute 77.09 ± 11.83 76.39 ± 11.4 0.828
20th Minute 75.46 ± 13.82 77.05 ± 10.46 0.704
25th Minute 77.6 ± 14.74 77.9 ± 14.17 0.964
30th Minute 79 ± 22.07 78.13 ± 12.15 0.933
P 0.770 0.0001*
Table 6 - Mean RSS Values of the Group.
RSS Group PF Group PA p
1st Minute 4.85 ± 0.43 4.8 ± 0.69 0.697
5th Minute 3.93 ± 1.12 3.78 ± 1.03 0.534
10th Minute 3.7 ± 0.91 3.41 ± 1.09 0.207
15th Minute 3.68 ± 1.04 3.35 ± 0.84 0.212
20th Minute 3.29 ± 0.73 3.1 ± 1 0.543
25th Minute 3.1 ± 0.74 3.33 ± 0.87 0.534
30th Minute 2.25 ± 0.5 3 ± 0.82 0.134
P 0.0001* 0.017*
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Mean RSS values were similar when comparing the groups. 
Group PF’s mean RSS values differed signiﬁ cantly for record-
ing times (p = 0.0001). Group PF’s first and 5th minute 
mean RSS values were signiﬁ cantly higher than at other times 
(p = 0.002, p = 0.045) when no differences were noted. Group 
PA’s mean RSS values had signiﬁ cant differences during all the 
recording times (p = 0.017). Group PA’s ﬁ rst-minute mean RSS 
value was signiﬁ cantly higher than the 15th, 20th, 25th, and 
30th minute values (p = 0.002, p = 0.022) (Table 6).
The mean total propofol dose of Group PA was signiﬁ cantly 
higher than Group PF (p = 0.028) and the mean recovery time 
of Group PA was signiﬁ cantly longer than the recovery time 
of Group PF (p = 0.032). Mean discharge times and colonos-
copist and patient satisfaction scores were similar in both 
of the groups (Table 7).
Discussion
Propofol is a short-acting, intravenous hypnotic, which pro-
vides rapid and complete recovery from anesthesia. When 
propofol is used as the sole anesthetic agent for an invasive 
procedure, very high doses (14.9 mg.kg-1.h-1) are required for 
toleration of the procedure 2. Both direct myocardial depres-
sion and peripheral vasodilation are propofol’s cardiovascular 
depressant effects, which are dose and concentration de-
pendent 7,8. Complications, such as hypotension, respiratory 
depression, and decreased upper airway protective reﬂ ex 
activity can appear with the use of high-dose propofol 7. 
Because the propofol is insufﬁ cient for analgesia, combin-
ing propofol with an intravenous opioid is recommended to 
increase the quality of sedation 7,9.
Both alfentanil and fentanyl can be used safely in 
colonoscopy procedures. Fentanyl clinical potency is 3-10 
times that of alfentanil. Alfentanil, a tetrazole derivative of 
fentanyl, crosses rapidly to highly perfused tissues like those 
of the brain, then distributes to the peripheral tissues. Both 
alfentanil and fentanyl cross the blood brain barrier rapidly. 
Alfentanil has rapid onset and produces unconsciousness 50 
seconds after administration. Respiratory depression and 
unconsciousness occur at the same time with alfentanil; 
however, unconsciousness occurs 30-60 seconds after respira-
tory depression in fentanyl because fentanyl has higher lipid 
solubility than alfentanil and fentanyl’s plasma concentra-
tion accumulates in tissue compartments before the onset 
of sufﬁ cient opioid effects. Less accumulation of alfentanil 
provides greater binding of plasma concentrations to opioid 
receptors and a more rapid onset of effects 8,10.
Because the propofol and alfentanil have rapid onset and 
are short acting, they are useful for sedation-analgesia 11 and 
the propofol-alfentanil combination is successful in analgesia 9. 
Avramov et al. reported that the propofol-combined opioid 
provides analgesia and amnesia, as well as reduces incidences 
of nausea, vomiting, and respiratory depression 12. In the 
current study, only one patient had nausea and vomiting; 
this patient was in Group PA.
Despite the appropriate sedation level achieved in opi-
oid use, colonoscopy patients experienced decreased upper 
airway protective reﬂ ex activity and upper airway manage-
ment problems 7. Alfentanil, as a short-acting opioid, was 
recommended for short procedures but when used as a sole 
agent, reports indicate that intraoperative and postoperative 
respiratory depression occurred more frequently 12,13. In the 
current study, the incidence of respiratory complications 
was higher in Group PA than in Group PF. Although there was 
no respiratory depression, 8 patients from Group PF and 12 
from Group PA experienced desaturation. These patients 
did not need endotracheal intubation or mask ventilation; 
vocal or tactile stimuli produced adequate recovery from 
desaturation.
Roseveare et al. suggested that the propofol-alfentanil 
combination was more short-acting and effective than 
benzodiazepines were in colonoscopy screening 14. Külling 
et al. compared the propofol-alfentanil combination with 
midazolam and meperidine. They reported that the propofol-
alfentanil combination resulted in more rapid recovery and 
increased patient satisfaction in colonoscopy 15. 
In one study of midazolam combinations, researchers 
compared meperidine, alfentanil, fentanyl, and sufentanil 
combinations in gastroscopy. Recovery times were report-
edly shorter in the sufentanil and alfentanil groups 16. In 
Holloway et al.’s study, midazolam combined with alfentanil 
and fentanyl were compared in colonoscopy. They reported 
that although alfentanil and fentanyl had similar recovery 
times, alfentanil provided better operative conditions 17. The 
current study compared propofol combined with fentanyl 
and alfentanil but the results did not conﬁ rm the previous 
studies. Recovery time was shorter and the mean propofol 
dose was less in Group PF than in Group PA.
The mean colonoscopy times were 20, 68 ± 10, 2 minutes 
in Group PA and 17, 5 ± 7, 39 minutes in Group PF. Because 
alfentanil acting time is shorter than the colonoscopy time, 
additional propofol doses were needed, and the 15th minute 
MAP values were higher in Group PA than in Group PF. Group 
PA’s beginning mean heart rate was higher than at subsequent 
recording times, which researchers related to the additional 
doses of propofol. None of our patients had hypotension or 
bradycardia.
In our study, we used RSS for the evaluation of seda-
tion level. Mean RSS values were similar in both of the 
groups. Bispectral Index (BIS) could be used to regulate 
Table 7 - Distribution of Total Propofol Doses, Recovery Time, Discharge Time, and Colonoscopist and Patient Satisfaction 
Scores in Groups.
Group PF Group PA p
Total Propofol Dose (mg) 148 ± 38.13 170.5 ± 50.95 0.028*
Recovery Time (minute) 18.88 ± 6.76 23.1 ± 10.2 0.032*
Discharge Time (minute) 31.37 ± 9.55 35.31 ± 13.06 0.136
Colonoscopist’s Satisfaction Score 9.25 ± 0.84 9.33 ± 1.31 0.761
Patient’s Satisfaction Score 9.38 ± 0.87 9.48 ± 0.82 0.597
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the appropriate sedation level and to reduce the dosage of 
sedatives during endoscopy. There are studies that compare 
the use of RSS and BIS 18-20. One of these studies reported 
that the BIS was the method recommended for monitoring 
patients under sedation and BIS monitoring could prevent 
oversedation and related complications 18. In this study, we 
consider RSS insufﬁ cient to evaluate oversedation 18. Not 
using BIS monitoring could be considered the negative side 
of our study. Nonetheless, there are studies comparing RSS 
and BIS that reported evaluations of sedation levels and the 
dosage of sedatives used were similar 19,20. Since our country 
is a developing one, acquiring BIS monitor and electrodes is 
hard and expensive. In similar studies from our country, RSS 
was used for the evaluation of sedation level 21.
A most signiﬁ cant ﬁ nding is that the patient/colonosco-
pist satisfaction scores were similar and high in both of the 
groups. This emphasizes that sedation-analgesia is the golden 
key for a comfortable and safe colonoscopy experience.
Because fentanyl has a longer acting time than alfentanil, 
fentanyl provides better operative conditions and reduces 
the need for an additional propofol dose, which results in a 
shorter recovery time. The propofol-fentanyl combination is 
superior to the propofol-alfentanil combination for sedation-
analgesia in colonoscopy procedures.
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